Search Results 931-940 of 4066 for 搜索痕迹咨询邮箱:lgooxc@hotmail.com
Phase 1-2 dose escalation randomized study in patients with intermediate or high risk myelodysplastic syndromes (MDS) or acute myelogenous leukemia (AML). The ...
The Mayo Clinic Kern Center for the Science of Health Care Delivery's multidisciplinary faculty guides research on the delivery of evidence-based, ...
Minimal residual disease (MRD) detection using circulating tumor DNA (ctDNA). MRD detection from proximal biofluids to anticipate cancer relapse.
The purpose of this study is to determine if microbiome DNA can be detected in the juice from the upper GI tract and that of the clinical residual specimens ...
To evaluate the impact of the developed decision aid (BE Choice) on patient-centered outcomes, assessments will be made of patient knowledge, decision conflict, ...
About this study. This is a phase 3, randomized, double-blind, multicenter study to evaluate the safety and efficacy of IXAZOMIB versus placebo when added ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This study is to learn how effective a night of no sleep, with or without light therapy, is for patients in an inpatient setting who are experiencing Major ...
Dr. Cerhan's team in the Lymphoma Epidemiology Lab at Mayo Clinic has expertise in cancer epidemiology, hematology, immunology, laboratory medicine and ...
The purpose of this study is to provide asthma management in the retail clinic setting in order to increase standardized asthma quality metrics in the Mayo ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.